Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic Disease

NCT02469701 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Lack of accrual

Conditions

Non-small Cell Lung Cancer
Lung Cancer
Metastatic Lung Cancer
NSCLC

Interventions

DRUG: nivolumab and ablation

Sponsor

howard safran

Collaborators

[object Object]
[object Object]